Showing results (161-170 of 396) with videos related to

Sort By:
Pageof 40
Cancer Research|January 11, 2007
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cellsKeiran S M Smalley, Rooha Contractor, Nikolas K Haass, et al.
Cardiovascular Research|December 9, 2003
Differential cyclin E expression in human in-stent stenosis smooth muscle cells identifies targets for selective anti-restenosis therapyMichael O'Sullivan, Stephen D Scott, Nicola McCarthy, et al.
Cancer Discovery|September 27, 2014
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFαMichael P Smith, Berta Sanchez-Laorden, Kate O'Brien, et al.
Stroke|July 9, 2021
CRP (C-Reactive Protein) in Outcome Prediction After Subarachnoid Hemorrhage and the Role of Machine LearningBen Gaastra, Peter Barron, Laura Newitt, et al.
Cancer Research|June 17, 2010
Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte functionAndrea Boni, Alexandria P Cogdill, Ping Dang, et al.
Cancer Cell|December 9, 2008
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinomaJohn D Gordan, Priti Lal, Vijay R Dondeti, et al.
Clinical Epigenetics|June 9, 2015
MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603Liza C Villaruz, Grace Huang, Marjorie Romkes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2017
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant MelanomaHeike Niessner, Tobias Sinnberg, Corinna Kosnopfel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapiesSelma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Pageof 40